Concourse Financial Group Securities, Inc. Hcw Biologics Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HCWB
# of Institutions
15Shares Held
1.14MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.14 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$992,0840.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$966,8250.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$538,5190.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$306,4730.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $146M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...